Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?

The temporary loosening of regulations governing methadone and buprenorphine treatment for opioid use disorder (OUD) in the U.S., instituted to prevent the spread of COVID-19, has created an opportunity to explore the effectiveness of new models of care for people with OUD. The opioid cascade descri...

Descripción completa

Detalles Bibliográficos
Autores principales: Nunes, Edward V., Levin, Frances R., Reilly, Muredach P., El-Bassel, Nabila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666540/
https://www.ncbi.nlm.nih.gov/pubmed/33221125
http://dx.doi.org/10.1016/j.jsat.2020.108196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666540/
https://www.ncbi.nlm.nih.gov/pubmed/33221125
http://dx.doi.org/10.1016/j.jsat.2020.108196

Ejemplares similares